In this regard, previous reports have identified CD39 as a marker of extended T cell activation [29] or tumor-specific TILs in CRC [12], which encouraged us to functionally compare CD103+CD8+ TRM cells from CRLM vs. liver. This evidence concerns the gene CD8A and neoplasm.